Haemonetics (HAE) Net Cash Flow Growth (5y) (2014 - 2026)
Haemonetics (HAE) Net Cash Flow Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.33 Bn | 174.04 Bn | 6.27 Bn |
| 2 | Stryker | 128.11 Bn | 125.23 Bn | 3.81 Bn |
| 3 | Medtronic | 107.76 Bn | 98.54 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.95 Bn | 66.50 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.43 Bn | 26.14 Bn | 1.98 Bn |
| 7 | Dexcom | 28.31 Bn | 27.20 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.77 Bn | 26.19 Bn | - |
| 9 | Koninklijke Philips | 25.33 Bn | 22.21 Bn | 2.07 Bn |
| 10 | Haemonetics | 3.79 Bn | 3.54 Bn | 198.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -89.61% |
| Dec 27, 2025 | 22.06% |
| Sep 27, 2025 | 16.88% |
| Jun 28, 2025 | -16.35% |
| Mar 29, 2025 | -27.22% |
| Dec 28, 2024 | 15.93% |
| Sep 28, 2024 | 8.43% |
| Jun 29, 2024 | 52.02% |
| Mar 30, 2024 | -23.44% |
| Dec 30, 2023 | -28.53% |
| Sep 30, 2023 | 48.68% |
| Jul 1, 2023 | -25.98% |
| Apr 1, 2023 | 23.06% |
| Dec 31, 2022 | -19.72% |
| Oct 1, 2022 | -0.54% |
| Jul 2, 2022 | -26.76% |
| Apr 2, 2022 | 20.98% |
| Jan 1, 2022 | 51.52% |
| Oct 2, 2021 | -1.00% |
| Jul 3, 2021 | -50.72% |